Science for Welfare, Innovations and Forceful Therapies (SWIFT)
Nauka dla dobra społecznego, innowacji i skutecznych terapii (SWIFT)

Funding source:
International Research Agenda programme (IRAP) of the Foundation for Polish Science (FNP) financed by the European Funds for a Smart Economy 2021-2027 (FENG), Priority FENG.02 Innovation-friendly environment, Measure FENG.02.01 International Research Agendas
Project Duration:
01.06.2024-31.05.2029
Principal Investigator:
prof. Natalia Marek-Trzonkowska
Funding amount:
30 000 000 PLN
(~6,7 million EUR)
Funding agreement / decision number:
FENG.02.01-IP.05-0031/23
Project Duration:
01.09.2023-31.08.2027
Principal Investigator:
Izabela Raszczyk, MBA
Funding amount:
3 093 030 €;
ICCVS UG: 568 450 €
Funding agreement / decision number:
GA no. 101120502
Project Duration:
01.12.2023-30.11.2027
Principal Investigator:
dr hab. Wojciech Siwek
Funding amount:
3 113 200 PLN
(~837 000 €)
Funding agreement / decision number:
UMO-2022/47/D/NZ1/01883
Project Duration:
01.09.2021-31.08.2026
Principal Investigator:
dr hab. eng. Monikaben Padariya
(prof. Ted Hupp until 03/2025)
Funding amount:
3 098 035 PLN;
ICCVS UG:
1 664 355 PLN (~370 000 €)
Funding agreement / decision number:
UMO-2020/39/B/NZ7/02677
Project Duration:
01.09.2022-28.02.2027
Principal Investigator:
dr Alicja Sznarkowska
Funding amount:
1 776 908 PLN
(~396 000 €)
Funding agreement / decision number:
UMO-2021/43/D/NZ1/02059
UltiMate 3000 RSLCnano tandem mass analyzer with quadrupole and Fourier detection
Tandemowy analizator mas z kwadrupolem i detekcją fourierowską UltiMate 3000 RSLCnano

Funding source:
Ministry of Science and Higher Education
Project Duration:
03.09.2024-31.12.2026
Principal Investigator:
dr Sachin Kote
Funding amount:
1 367 730 PLN
(~318 080 €)
Funding agreement / decision number:
58/596898/SPUB/SP/2024
Use of comparative oncology approach to dissect the PD-1 intrinsic signalling in osteosarcoma. Can dog be the key for next generation osteosarcoma treatments?
Analiza wewnątrzkomórkowej ścieżki sygnalizacyjnej PD-1 w kostniakomięsaku z użyciem medycyny porównawczej. Czy pies jest kluczem do następnej generacji leków na kostniakomięsaka?
Funding source:
National Science Centre (NCN), PRELUDIUM
Project Duration:
03.02.2023-02.02.2027
Principal Investigator:
dr Katarzyna Dziubek
Funding amount:
210 000 PLN
(~46 667 €)
Funding agreement / decision number:
UMO-2022/45/N/NZ1/02699
Project Duration:
05.12.2025-05.12.2026
Principal Investigator:
dr Justyna Topa
Funding amount:
49 998 PLN
Funding agreement / decision number:
DEC-2025/09/X/NZ1/01864
